APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular Diagnostic Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cardiovascular Diagnostic Testing Market Outlook and Growth Opportunities 2026

4 July 2026195 pages

Choose your research edition.

Industry ResearchCardiovascular Diagnostic Testing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular Diagnostic Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cardiovascular Diagnostic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular Diagnostic Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiovascular Diagnostic Testing Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cardiovascular Diagnostic Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cardiovascular Diagnostic Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cardiovascular Diagnostic Testing market include Abbott Laboratories, BD, bioMérieux, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche, PerkinElmer, Siemens AG and Tosoh Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cardiovascular Diagnostic Testing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiovascular Diagnostic Testing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiovascular Diagnostic Testing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiovascular Diagnostic Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiovascular Diagnostic Testing Segment by Company

Abbott Laboratories

BD

bioMérieux

Bio-Rad Laboratories

Danaher Corporation

F. Hoffmann-La Roche

PerkinElmer

Siemens AG

Tosoh Corporation

Thermo Fisher Scientific

Cardiovascular Diagnostic Testing Segment by Type

Fibrinogen Test

Angiotensin Test

Serum Uric Acid Test

Lipoprotein Test

Cardiovascular Diagnostic Testing Segment by Application

Laboratory Testing Facilities

Point-of-care Testing Facilities

Cardiovascular Diagnostic Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cardiovascular Diagnostic Testing status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cardiovascular Diagnostic Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cardiovascular Diagnostic Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Cardiovascular Diagnostic Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Diagnostic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Diagnostic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Diagnostic Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cardiovascular Diagnostic Testing market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiovascular Diagnostic Testing industry.

Chapter 3: Detailed analysis of Cardiovascular Diagnostic Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cardiovascular Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cardiovascular Diagnostic Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cardiovascular Diagnostic Testing Industry Trends Table 2. Cardiovascular Diagnostic Testing Industry Drivers Table 3. Cardiovascular Diagnostic Testing Industry Opportunities and Challenges Table 4. Cardiovascular Diagnostic Testing Industry Restraints Table 5. Global Cardiovascular Diagnostic Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cardiovascular Diagnostic Testing Revenue Share by Company (2021-2026) Table 7. Global Cardiovascular Diagnostic Testing Sales Volume by Company (k units) & (2021-2026) Table 8. Global Cardiovascular Diagnostic Testing Sales Volume Share by Company (2021-2026) Table 9. Global Cardiovascular Diagnostic Testing Average Price (USD/unit) of Company (2021-2026) Table 10. Global Cardiovascular Diagnostic Testing Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cardiovascular Diagnostic Testing Key Company Manufacturing Base & Headquarters Table 12. Global Cardiovascular Diagnostic Testing Company, Product Type & Application Table 13. Global Cardiovascular Diagnostic Testing Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cardiovascular Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fibrinogen Test Table 18. Significant Companies of Angiotensin Test Table 19. Significant Companies of Serum Uric Acid Test Table 20. Significant Companies of Lipoprotein Test Table 21. Global Cardiovascular Diagnostic Testing Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Cardiovascular Diagnostic Testing Sales Volume by Type (2021-2026) & (k units) Table 23. Global Cardiovascular Diagnostic Testing Sales Volume by Type (2027-2032) & (k units) Table 24. Global Cardiovascular Diagnostic Testing Sales Volume Share by Type (2021-2026) Table 25. Global Cardiovascular Diagnostic Testing Sales Volume Share by Type (2027-2032) Table 26. Global Cardiovascular Diagnostic Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cardiovascular Diagnostic Testing Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Cardiovascular Diagnostic Testing Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Cardiovascular Diagnostic Testing Sales Value Share by Type (2021-2026) Table 30. Global Cardiovascular Diagnostic Testing Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Laboratory Testing Facilities Table 32. Significant Companies of Point-of-care Testing Facilities Table 33. Global Cardiovascular Diagnostic Testing Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Cardiovascular Diagnostic Testing Sales Volume by Application (2021-2026) & (k units) Table 35. Global Cardiovascular Diagnostic Testing Sales Volume by Application (2027-2032) & (k units) Table 36. Global Cardiovascular Diagnostic Testing Sales Volume Share by Application (2021-2026) Table 37. Global Cardiovascular Diagnostic Testing Sales Volume Share by Application (2027-2032) Table 38. Global Cardiovascular Diagnostic Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Cardiovascular Diagnostic Testing Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Cardiovascular Diagnostic Testing Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Cardiovascular Diagnostic Testing Sales Value Share by Application (2021-2026) Table 42. Global Cardiovascular Diagnostic Testing Sales Value Share by Application (2027-2032) Table 43. Global Cardiovascular Diagnostic Testing Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Cardiovascular Diagnostic Testing Sales by Region (2021-2026) & (k units) Table 45. Global Cardiovascular Diagnostic Testing Sales Market Share by Region (2021-2026) Table 46. Global Cardiovascular Diagnostic Testing Sales by Region (2027-2032) & (k units) Table 47. Global Cardiovascular Diagnostic Testing Sales Market Share by Region (2027-2032) Table 48. Global Cardiovascular Diagnostic Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Cardiovascular Diagnostic Testing Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Cardiovascular Diagnostic Testing Sales Value Share by Region (2021-2026) Table 51. Global Cardiovascular Diagnostic Testing Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Cardiovascular Diagnostic Testing Sales Value Share by Region (2027-2032) Table 53. Global Cardiovascular Diagnostic Testing Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Cardiovascular Diagnostic Testing Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Cardiovascular Diagnostic Testing Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Cardiovascular Diagnostic Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Cardiovascular Diagnostic Testing Sales by Country (2021-2026) & (k units) Table 58. Global Cardiovascular Diagnostic Testing Sales Market Share by Country (2021-2026) Table 59. Global Cardiovascular Diagnostic Testing Sales by Country (2027-2032) & (k units) Table 60. Global Cardiovascular Diagnostic Testing Sales Market Share by Country (2027-2032) Table 61. Global Cardiovascular Diagnostic Testing Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Cardiovascular Diagnostic Testing Sales Value Market Share by Country (2021-2026) Table 63. Global Cardiovascular Diagnostic Testing Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Cardiovascular Diagnostic Testing Sales Value Market Share by Country (2027-2032) Table 65. Abbott Laboratories Company Information Table 66. Abbott Laboratories Business Overview Table 67. Abbott Laboratories Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Abbott Laboratories Cardiovascular Diagnostic Testing Product Portfolio Table 69. Abbott Laboratories Recent Development Table 70. BD Company Information Table 71. BD Business Overview Table 72. BD Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. BD Cardiovascular Diagnostic Testing Product Portfolio Table 74. BD Recent Development Table 75. bioMérieux Company Information Table 76. bioMérieux Business Overview Table 77. bioMérieux Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. bioMérieux Cardiovascular Diagnostic Testing Product Portfolio Table 79. bioMérieux Recent Development Table 80. Bio-Rad Laboratories Company Information Table 81. Bio-Rad Laboratories Business Overview Table 82. Bio-Rad Laboratories Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Bio-Rad Laboratories Cardiovascular Diagnostic Testing Product Portfolio Table 84. Bio-Rad Laboratories Recent Development Table 85. Danaher Corporation Company Information Table 86. Danaher Corporation Business Overview Table 87. Danaher Corporation Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Danaher Corporation Cardiovascular Diagnostic Testing Product Portfolio Table 89. Danaher Corporation Recent Development Table 90. F. Hoffmann-La Roche Company Information Table 91. F. Hoffmann-La Roche Business Overview Table 92. F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Product Portfolio Table 94. F. Hoffmann-La Roche Recent Development Table 95. PerkinElmer Company Information Table 96. PerkinElmer Business Overview Table 97. PerkinElmer Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. PerkinElmer Cardiovascular Diagnostic Testing Product Portfolio Table 99. PerkinElmer Recent Development Table 100. Siemens AG Company Information Table 101. Siemens AG Business Overview Table 102. Siemens AG Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Siemens AG Cardiovascular Diagnostic Testing Product Portfolio Table 104. Siemens AG Recent Development Table 105. Tosoh Corporation Company Information Table 106. Tosoh Corporation Business Overview Table 107. Tosoh Corporation Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Tosoh Corporation Cardiovascular Diagnostic Testing Product Portfolio Table 109. Tosoh Corporation Recent Development Table 110. Thermo Fisher Scientific Company Information Table 111. Thermo Fisher Scientific Business Overview Table 112. Thermo Fisher Scientific Cardiovascular Diagnostic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Thermo Fisher Scientific Cardiovascular Diagnostic Testing Product Portfolio Table 114. Thermo Fisher Scientific Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Cardiovascular Diagnostic Testing Distributors List Table 118. Cardiovascular Diagnostic Testing Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Cardiovascular Diagnostic Testing Product Image Figure 2. Global Cardiovascular Diagnostic Testing Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiovascular Diagnostic Testing Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cardiovascular Diagnostic Testing Sales (2021-2032) & (k units) Figure 5. Global Cardiovascular Diagnostic Testing Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Cardiovascular Diagnostic Testing Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fibrinogen Test Image Figure 10. Angiotensin Test Image Figure 11. Serum Uric Acid Test Image Figure 12. Lipoprotein Test Image Figure 13. Global Cardiovascular Diagnostic Testing Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Cardiovascular Diagnostic Testing Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Cardiovascular Diagnostic Testing Sales Volume Share by Type (2021-2032) Figure 16. Global Cardiovascular Diagnostic Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cardiovascular Diagnostic Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cardiovascular Diagnostic Testing Sales Value Share by Type (2021-2032) Figure 19. Laboratory Testing Facilities Image Figure 20. Point-of-care Testing Facilities Image Figure 21. Global Cardiovascular Diagnostic Testing Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Cardiovascular Diagnostic Testing Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Cardiovascular Diagnostic Testing Sales Volume Share by Application (2021-2032) Figure 24. Global Cardiovascular Diagnostic Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Cardiovascular Diagnostic Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Cardiovascular Diagnostic Testing Sales Value Share by Application (2021-2032) Figure 27. Global Cardiovascular Diagnostic Testing Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Cardiovascular Diagnostic Testing Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Cardiovascular Diagnostic Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Cardiovascular Diagnostic Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Cardiovascular Diagnostic Testing Sales Value (2021-2032) & (US$ Million) Figure 32. North America Cardiovascular Diagnostic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Cardiovascular Diagnostic Testing Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Cardiovascular Diagnostic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Cardiovascular Diagnostic Testing Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Cardiovascular Diagnostic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Cardiovascular Diagnostic Testing Sales Value (2021-2032) & (US$ Million) Figure 38. South America Cardiovascular Diagnostic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Cardiovascular Diagnostic Testing Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Cardiovascular Diagnostic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Cardiovascular Diagnostic Testing Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Cardiovascular Diagnostic Testing Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Fibrinogen Test
  • Angiotensin Test
  • Serum Uric Acid Test
  • Lipoprotein Test
Applications
  • Laboratory Testing Facilities
  • Point-of-care Testing Facilities
Companies covered
  • Abbott Laboratories
  • BD
  • bioMérieux
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche
  • PerkinElmer
  • Siemens AG
  • Tosoh Corporation
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiovascular Diagnostic Testing Sales Value (2021-2032)
  4. 1.2.2 Global Cardiovascular Diagnostic Testing Sales Volume (2021-2032)
  5. 1.2.3 Global Cardiovascular Diagnostic Testing Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cardiovascular Diagnostic Testing Market Dynamics
  1. 2.1 Cardiovascular Diagnostic Testing Industry Trends
  2. 2.2 Cardiovascular Diagnostic Testing Industry Drivers
  3. 2.3 Cardiovascular Diagnostic Testing Industry Opportunities and Challenges
  4. 2.4 Cardiovascular Diagnostic Testing Industry Restraints
3 Cardiovascular Diagnostic Testing Market by Company
  1. 3.1 Global Cardiovascular Diagnostic Testing Company Revenue Ranking in 2025
  2. 3.2 Global Cardiovascular Diagnostic Testing Revenue by Company (2021-2026)
  3. 3.3 Global Cardiovascular Diagnostic Testing Sales Volume by Company (2021-2026)
  4. 3.4 Global Cardiovascular Diagnostic Testing Average Price by Company (2021-2026)
  5. 3.5 Global Cardiovascular Diagnostic Testing Company Ranking (2024-2026)
  6. 3.6 Global Cardiovascular Diagnostic Testing Company Manufacturing Base and Headquarters
  7. 3.7 Global Cardiovascular Diagnostic Testing Company Product Type and Application
  8. 3.8 Global Cardiovascular Diagnostic Testing Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cardiovascular Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cardiovascular Diagnostic Testing Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cardiovascular Diagnostic Testing Market by Type
  1. 4.1 Cardiovascular Diagnostic Testing Type Introduction
  2. 4.1.1 Fibrinogen Test
  3. 4.1.2 Angiotensin Test
  4. 4.1.3 Serum Uric Acid Test
  5. 4.1.4 Lipoprotein Test
  6. 4.2 Global Cardiovascular Diagnostic Testing Sales Volume by Type
  7. 4.2.1 Global Cardiovascular Diagnostic Testing Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cardiovascular Diagnostic Testing Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Cardiovascular Diagnostic Testing Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Cardiovascular Diagnostic Testing Sales Value by Type
  11. 4.3.1 Global Cardiovascular Diagnostic Testing Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cardiovascular Diagnostic Testing Sales Value by Type (2021-2032)
  13. 4.3.3 Global Cardiovascular Diagnostic Testing Sales Value Share by Type (2021-2032)
5 Cardiovascular Diagnostic Testing Market by Application
  1. 5.1 Cardiovascular Diagnostic Testing Application Introduction
  2. 5.1.1 Laboratory Testing Facilities
  3. 5.1.2 Point-of-care Testing Facilities
  4. 5.2 Global Cardiovascular Diagnostic Testing Sales Volume by Application
  5. 5.2.1 Global Cardiovascular Diagnostic Testing Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cardiovascular Diagnostic Testing Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Cardiovascular Diagnostic Testing Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Cardiovascular Diagnostic Testing Sales Value by Application
  9. 5.3.1 Global Cardiovascular Diagnostic Testing Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Cardiovascular Diagnostic Testing Sales Value by Application (2021-2032)
  11. 5.3.3 Global Cardiovascular Diagnostic Testing Sales Value Share by Application (2021-2032)
6 Cardiovascular Diagnostic Testing Regional Sales and Value Analysis
  1. 6.1 Global Cardiovascular Diagnostic Testing Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiovascular Diagnostic Testing Sales by Region (2021-2032)
  3. 6.2.1 Global Cardiovascular Diagnostic Testing Sales by Region: 2021-2026
  4. 6.2.2 Global Cardiovascular Diagnostic Testing Sales by Region (2027-2032)
  5. 6.3 Global Cardiovascular Diagnostic Testing Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cardiovascular Diagnostic Testing Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cardiovascular Diagnostic Testing Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cardiovascular Diagnostic Testing Sales Value by Region (2027-2032)
  9. 6.5 Global Cardiovascular Diagnostic Testing Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cardiovascular Diagnostic Testing Sales Value (2021-2032)
  12. 6.6.2 North America Cardiovascular Diagnostic Testing Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cardiovascular Diagnostic Testing Sales Value (2021-2032)
  15. 6.7.2 Europe Cardiovascular Diagnostic Testing Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cardiovascular Diagnostic Testing Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cardiovascular Diagnostic Testing Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cardiovascular Diagnostic Testing Sales Value (2021-2032)
  21. 6.9.2 South America Cardiovascular Diagnostic Testing Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cardiovascular Diagnostic Testing Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cardiovascular Diagnostic Testing Sales Value Share by Country, 2025 VS 2032
7 Cardiovascular Diagnostic Testing Country-level Sales and Value Analysis
  1. 7.1 Global Cardiovascular Diagnostic Testing Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cardiovascular Diagnostic Testing Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
  4. 7.3.1 Global Cardiovascular Diagnostic Testing Sales by Country (2021-2026)
  5. 7.3.2 Global Cardiovascular Diagnostic Testing Sales by Country (2027-2032)
  6. 7.4 Global Cardiovascular Diagnostic Testing Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cardiovascular Diagnostic Testing Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cardiovascular Diagnostic Testing Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cardiovascular Diagnostic Testing Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cardiovascular Diagnostic Testing Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cardiovascular Diagnostic Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Cardiovascular Diagnostic Testing Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 BD
  8. 8.2.1 BD Company Information
  9. 8.2.2 BD Business Overview
  10. 8.2.3 BD Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BD Cardiovascular Diagnostic Testing Product Portfolio
  12. 8.2.5 BD Recent Developments
  13. 8.3 bioMérieux
  14. 8.3.1 bioMérieux Company Information
  15. 8.3.2 bioMérieux Business Overview
  16. 8.3.3 bioMérieux Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 bioMérieux Cardiovascular Diagnostic Testing Product Portfolio
  18. 8.3.5 bioMérieux Recent Developments
  19. 8.4 Bio-Rad Laboratories
  20. 8.4.1 Bio-Rad Laboratories Company Information
  21. 8.4.2 Bio-Rad Laboratories Business Overview
  22. 8.4.3 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Product Portfolio
  24. 8.4.5 Bio-Rad Laboratories Recent Developments
  25. 8.5 Danaher Corporation
  26. 8.5.1 Danaher Corporation Company Information
  27. 8.5.2 Danaher Corporation Business Overview
  28. 8.5.3 Danaher Corporation Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Corporation Cardiovascular Diagnostic Testing Product Portfolio
  30. 8.5.5 Danaher Corporation Recent Developments
  31. 8.6 F. Hoffmann-La Roche
  32. 8.6.1 F. Hoffmann-La Roche Company Information
  33. 8.6.2 F. Hoffmann-La Roche Business Overview
  34. 8.6.3 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Product Portfolio
  36. 8.6.5 F. Hoffmann-La Roche Recent Developments
  37. 8.7 PerkinElmer
  38. 8.7.1 PerkinElmer Company Information
  39. 8.7.2 PerkinElmer Business Overview
  40. 8.7.3 PerkinElmer Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 PerkinElmer Cardiovascular Diagnostic Testing Product Portfolio
  42. 8.7.5 PerkinElmer Recent Developments
  43. 8.8 Siemens AG
  44. 8.8.1 Siemens AG Company Information
  45. 8.8.2 Siemens AG Business Overview
  46. 8.8.3 Siemens AG Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Siemens AG Cardiovascular Diagnostic Testing Product Portfolio
  48. 8.8.5 Siemens AG Recent Developments
  49. 8.9 Tosoh Corporation
  50. 8.9.1 Tosoh Corporation Company Information
  51. 8.9.2 Tosoh Corporation Business Overview
  52. 8.9.3 Tosoh Corporation Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Tosoh Corporation Cardiovascular Diagnostic Testing Product Portfolio
  54. 8.9.5 Tosoh Corporation Recent Developments
  55. 8.10 Thermo Fisher Scientific
  56. 8.10.1 Thermo Fisher Scientific Company Information
  57. 8.10.2 Thermo Fisher Scientific Business Overview
  58. 8.10.3 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cardiovascular Diagnostic Testing Value Chain Analysis
  2. 9.1.1 Cardiovascular Diagnostic Testing Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cardiovascular Diagnostic Testing Sales Mode & Process
  6. 9.2 Cardiovascular Diagnostic Testing Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cardiovascular Diagnostic Testing Distributors
  9. 9.2.3 Cardiovascular Diagnostic Testing Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst